US Navy cancels MASC programme, launches $2.1bn MUSV marketplace as the Golden Fleet strategy moves from concept to procurement
No Kings protests return to New York City for third time as nationwide mobilisation targets Trump administration policies
Read More 2 minute read Pharma Industry News bluebird bio unveils US commercial strategy for LYFGENIA gene therapy bluebird bio, Inc., a pioneer in the biotechnology industry, has announced the U.S. commercial infrastructure for LYFGENIA (lovotibeglogene… byPallavi MadhirajuDecember 9, 2023